As outside experts gathered for a…
As outside experts gathered for a second day to discuss [...]
As outside experts gathered for a second day to discuss [...]
The company is targeting Lilly ad campaigns that cite what [...]
With all eyes on Tavneos’ seemingly precarious approval status in [...]
Three years after gaining three liver disease assets in its [...]
A survey of 36 U.S. gastroenterologists found that significant treatment [...]
Generic drugmakers will face import tariffs in the U.S., President [...]
An FDA advisory committee has recommended that four peptide drugs [...]
On an investor call Thursday, Roche Pharmaceuticals CEO Teresa Graham [...]
The former quarterback spoke with Fierce Pharma Marketing on teaming [...]
In a landmark moment for its oncology ambitions, GSK has [...]